# Study Comparing HAI Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM

> **NCT03125161** · PHASE3 · UNKNOWN · sponsor: **Fudan University** · enrollment: 150 (estimated)

## Conditions studied

- Colorectal Adenocarcinoma Metastatic to the Liver

## Interventions

- **DRUG:** HAI
- **DRUG:** chemotherapy ± target therapy

## Key facts

- **NCT ID:** NCT03125161
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-30
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2017-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03125161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03125161, "Study Comparing HAI Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03125161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*